HALEOSLABS vs ZIMLAB: Stock Comparison

Haleos Labs Limited vs Zim Laboratories Limited

Live data: 22 July 2026, 3:05 PM IST • Source: NSE and company filings

Zim Laboratories Limited is the larger company by market capitalisation. Haleos Labs Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Zim Laboratories Limited shows lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Haleos Labs Limited and Zim Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, HALEOSLABS is more favourable on 10 of 13 scored metrics and ZIMLAB on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ZIMLAB is the larger company
₹656 Cr vs ₹484 Cr
P/E Ratio
HALEOSLABS has a lower P/E
27.94x vs 112.39x
P/B Ratio
ZIMLAB has a lower P/B
2.21x vs 2.27x
EPS
HALEOSLABS has higher earnings per share
₹57.3 vs ₹1.94
Dividend Yield
HALEOSLABS has a higher dividend yield
0.1% vs 0.02%
Revenue Growth (TTM YoY)
HALEOSLABS has faster revenue growth
0% vs -3.36%
EPS Growth (TTM YoY)
HALEOSLABS has faster EPS growth
0% vs -47.01%
Qtr Sales Growth
ZIMLAB has stronger quarterly sales growth
-12.3% vs -15.7%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricHALEOSLABSZIMLAB
SectorHealthcare
IndustryPharmaceuticals

Price

MetricHALEOSLABSZIMLAB
Live Price₹1,522.4₹104.91
Day Change-3.09%0.25%
Volume28181,241
52-Week High₹1,774₹121.47
52-Week Low₹1,181₹59.31
Distance from 52W High-14.18%-13.63%

Valuation

MetricHALEOSLABSZIMLAB
Market Cap₹484 Cr₹656 Cr
P/E Ratio27.94x112.39x
P/B Ratio2.27x2.21x
EPS₹57.3₹1.94
Book Value₹706₹51.77
Dividend Yield0.1%0.02%

Growth

MetricHALEOSLABSZIMLAB
Revenue Growth (TTM YoY)0%-3.36%
EPS Growth (TTM YoY)0%-47.01%
Qtr Sales Growth-15.7%-12.3%
Qtr Profit Growth-85.2%-308%

Profitability & Leverage

MetricHALEOSLABSZIMLAB
ROE8.44%1.97%
ROCE9.91%8.16%
Net Margin5.33%1.56%
Operating Margin13.4%5.72%
Debt to Equity0.52x0.42x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricHALEOSLABSZIMLAB
Promoter Holding72.11%30.36% 0.01 pp
FII Holding0%0.03% 0.03 pp
DII Holding0.31% 0.01 pp1.33% 1.26 pp
Public Holding27.58% 0.02 pp68.28% 1.3 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Haleos Labs Limited and Zim Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.